The aim of this study is to examine the efficacy and safety of insulin dose adjustment education based on a smartphone PHR in patients with DM who initiate or intensify their basal insulin regimen and to confirm the validity and stability of the information and communication technology (ICT)-based centralized clinical trial monitoring system by analyzes using PHR- and questionnaire-based evaluation. The gene discussed is INS; the disease is diabetes mellitus.